97 related articles for article (PubMed ID: 25555152)
1. Engineering and exploitation of a fluorescent HIV-1 gp120 for live cell CD4 binding assays.
Costantini LM; Irvin SC; Kennedy SC; Guo F; Goldstein H; Herold BC; Snapp EL
Virology; 2015 Feb; 476():240-248. PubMed ID: 25555152
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood-retinal barrier.
Jiang J; Wang L; Li Q; Wang Y; Wang Z
AIDS; 2024 May; 38(6):779-789. PubMed ID: 38578957
[TBL] [Abstract][Full Text] [Related]
3. Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry.
Brandenberg OF; Magnus C; Rusert P; Regoes RR; Trkola A
PLoS Pathog; 2015 Jan; 11(1):e1004595. PubMed ID: 25569556
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies.
Lynch RM; Wong P; Tran L; O'Dell S; Nason MC; Li Y; Wu X; Mascola JR
J Virol; 2015 Apr; 89(8):4201-13. PubMed ID: 25631091
[TBL] [Abstract][Full Text] [Related]
5. Virological features associated with the development of broadly neutralizing antibodies to HIV-1.
Moore PL; Williamson C; Morris L
Trends Microbiol; 2015 Apr; 23(4):204-11. PubMed ID: 25572881
[TBL] [Abstract][Full Text] [Related]
6. Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties.
Guenaga J; de Val N; Tran K; Feng Y; Satchwell K; Ward AB; Wyatt RT
PLoS Pathog; 2015 Jan; 11(1):e1004570. PubMed ID: 25569572
[TBL] [Abstract][Full Text] [Related]
7. Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies.
Wang S; Mata-Fink J; Kriegsman B; Hanson M; Irvine DJ; Eisen HN; Burton DR; Wittrup KD; Kardar M; Chakraborty AK
Cell; 2015 Feb; 160(4):785-797. PubMed ID: 25662010
[TBL] [Abstract][Full Text] [Related]
8. Retroviral factors promoting infectivity.
Cuccurullo EC; Valentini C; Pizzato M
Prog Mol Biol Transl Sci; 2015; 129():213-51. PubMed ID: 25595806
[TBL] [Abstract][Full Text] [Related]
9. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
[TBL] [Abstract][Full Text] [Related]
10. Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env.
Guttman M; Cupo A; Julien JP; Sanders RW; Wilson IA; Moore JP; Lee KK
Nat Commun; 2015 Feb; 6():6144. PubMed ID: 25652336
[TBL] [Abstract][Full Text] [Related]
11. The cytoplasmic tail of retroviral envelope glycoproteins.
Tedbury PR; Freed EO
Prog Mol Biol Transl Sci; 2015; 129():253-84. PubMed ID: 25595807
[TBL] [Abstract][Full Text] [Related]
12. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.
Pugach P; Ozorowski G; Cupo A; Ringe R; Yasmeen A; de Val N; Derking R; Kim HJ; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; Julien JP; Burton DR; Wilson IA; Sanders RW; Klasse PJ; Ward AB; Moore JP
J Virol; 2015 Mar; 89(6):3380-95. PubMed ID: 25589637
[TBL] [Abstract][Full Text] [Related]
13. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.
Deng K; Pertea M; Rongvaux A; Wang L; Durand CM; Ghiaur G; Lai J; McHugh HL; Hao H; Zhang H; Margolick JB; Gurer C; Murphy AJ; Valenzuela DM; Yancopoulos GD; Deeks SG; Strowig T; Kumar P; Siliciano JD; Salzberg SL; Flavell RA; Shan L; Siliciano RF
Nature; 2015 Jan; 517(7534):381-5. PubMed ID: 25561180
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput HIV-Cell Fusion Assay for Discovery of Virus Entry Inhibitors.
Marin M; Du Y; Giroud C; Kim JH; Qui M; Fu H; Melikyan GB
Assay Drug Dev Technol; 2015 Apr; 13(3):155-66. PubMed ID: 25871547
[TBL] [Abstract][Full Text] [Related]
15. Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.
Schwalbe B; Schreiber M
PLoS One; 2015; 10(3):e0119879. PubMed ID: 25785610
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 gp120 dimers decrease the overall affinity of gp120 preparations for CD4-induced ligands.
Coutu M; Finzi A
J Virol Methods; 2015 Apr; 215-216():37-44. PubMed ID: 25712564
[TBL] [Abstract][Full Text] [Related]
17. Reply to "Can HIV-1 entry sites be deduced by comparing bulk endocytosis to functional readouts for viral fusion?".
Herold N; Müller B; Kräusslich HG
J Virol; 2015 Mar; 89(5):2986-7. PubMed ID: 25657215
[No Abstract] [Full Text] [Related]
18. Can HIV-1 entry sites be deduced by comparing bulk endocytosis to functional readouts for viral fusion?
Marin M; Melikyan GB
J Virol; 2015 Mar; 89(5):2985. PubMed ID: 25657214
[No Abstract] [Full Text] [Related]
19. The membrane proximal external regions of gp41 from HIV-1 strains HXB2 and JRFL have different sensitivities to alanine mutation.
Yi HA; Diaz-Rohrer B; Saminathan P; Jacobs A
Biochemistry; 2015 Mar; 54(8):1681-93. PubMed ID: 25649507
[TBL] [Abstract][Full Text] [Related]
20. Profilin1 regulates invadopodium maturation in human breast cancer cells.
Valenzuela-Iglesias A; Sharma VP; Beaty BT; Ding Z; Gutierrez-Millan LE; Roy P; Condeelis JS; Bravo-Cordero JJ
Eur J Cell Biol; 2015 Feb; 94(2):78-89. PubMed ID: 25613364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
